This article refers to the anti-tumor molecule and not the a2iib3 integrin activation specific antibody of the same namePAC-1 (first procaspase activating compound) is a synthesized chemical compound that selectively induces apoptosis or cell suicide in cancerous cells. PAC-1 has shown good results in mouse models and is being further evaluated for use in humans.
This page contains content from the copyrighted Wikipedia article "PAC-1"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
